Clinical Trial Update: Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates a conditioning regimen with fludarabine and busulfan followed by donor peripheral stem cell transplantation with antithymocyte glob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• METHOTREXATE (METHOTREXATE)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 2 | Status: COMPLETED